Indeed, Meis1 aberrant expression actively contributes to acute myeloid leukemia, whereas Fut8 overexpression has been found in non-hematopoietic cancer (Argiropoulos et al., 2007; Honma et al., 2015; Kumar et al., 2009; Liu et al., 2017; Wang et al., 2014). Here, MEIS1 is linked to hematopoietic and lymphoid cell neoplasm.